Hypesthesia: Clinical Trials

5 trials for Hypesthesia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 unknown. 5 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 2, Recruiting 2, Unknown 1
Phase 22Recruiting 2

Follow Hypesthesia: new trials by email Literature Review of Hypesthesia trials Research Report on Hypesthesia

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ozone Treatment in Paresthesia (Numbness, Tingling) Secondary to Chemotherapy-induced Peripheral Neuropathy
Ozone therapy, Oxygen (placebo) - Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia
Phase 2 / Phase 3RecruitingBernardino Clavo, MD, PhD422025-02-072026-09-18
Gut Microbiome Profiles in Patients With Chemotherapy-induced Neuropathy in the RCT OzoParQT (NCT06706544).
Ozone therapy, Oxygen (placebo) - Chemotherapy Induced Peripheral Neuropathy (CIPN), Paresthesia
Phase 2 / Phase 3RecruitingBernardino Clavo, MD, PhD422025-02-072026-09-25
Efficacy of Acupuncture in Prevention of Chemotherapy Induced Peripheral Neuropathy - a Pilot Study
Verum acupuncture - Colorectal Cancer
Phase 3UnknownTzu-Liang Chen322016-01-012016-04-21
Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures
Phentolamine Mesylate (NV-101) - Anesthesia, Dental
Phase 3CompletedNovalar Pharmaceuticals, Inc.2402006-02-012006-11-17
Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Mandibular Procedures
Phentolamine Mesylate (NV-101) - Anesthesia, Dental
Phase 3CompletedNovalar Pharmaceuticals, Inc.2402006-02-012006-11-17

Narrower conditions

Anxiety Disorders (2)  ·  Depression (2)  ·  Paresthesia (2)  ·  Colorectal Neoplasms (1)  ·  Peripheral Nervous System Diseases (1)

Broader conditions

Nervous System Diseases (5)  ·  Neurologic Manifestations (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Sensation Disorders (5)  ·  Signs and Symptoms (5)  ·  Somatosensory Disorders (5)  ·  Behavior (2)  ·  Behavioral Symptoms (2)  ·  Mental Disorders (2)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)

Interventions

Oxygen (2)  ·  Phentolamine (2)

Sponsors

Bernardino Clavo, MD, PhD (2)  ·  Novalar Pharmaceuticals, Inc. (2)  ·  Tzu-Liang Chen (1)

Countries

Spain (2)  ·  United States (2)  ·  Taiwan (1)

Top investigators

Athena Papas, DMD (2)  ·  Bernardino Clavo, MD, PhD (2)  ·  Himar Fabelo, BSc, PhD (1)  ·  Jacob Lorenzo-Morales, Prof (1)

Results publications

PMID 41572235